Dr. Subish Palaian is an Associate Professor at College of Pharmacy and Health Sciences, Ajman University. His research experience is mainly related to Pharmacovigilance and Drug Safety.
Education
PhD, College of Pharmacy, Universiti Sanis Malaysia, Penang, Malaysia, 2010
PhD, College of Pharmacy, Universiti Sanis Malaysia, Penang, Malaysia, 2010
M.Pharm, Manipal Academy of Higher Education, India, 2003
M.Pharm, Manipal Academy of Higher Education, India, 2003
B.Pharm, Rajiv Gandhi University of Health Sciences, India, 2000
B.Pharm, Rajiv Gandhi University of Health Sciences, India, 2000
Experience
Associate professor, Department of Pharmacy Practice, Gulf Medical University, Ajman, UAE, 4 years
Associate professor, Department of Pharmacy Practice, Gulf Medical University, Ajman, UAE, 4 years
Associate Professor, Department of Pharmacology and Chief of Hospital and Clincial Pharmacy, College of Medical Sciences, Bharatpur, Nepal, 5 years
Associate Professor, Department of Pharmacology and Chief of Hospital and Clincial Pharmacy, College of Medical Sciences, Bharatpur, Nepal, 5 years
Assistant Professor, Department of Pharmacology, Manipal College of Medical Sciences, Pokhara, Nepal, 3 years
Assistant Professor, Department of Pharmacology, Manipal College of Medical Sciences, Pokhara, Nepal, 3 years
Lecturer, Department of Pharmacology, Manipal College of Medical Sciences, Pokhara, Nepal, 3 years
Lecturer, Department of Pharmacology, Manipal College of Medical Sciences, Pokhara, Nepal, 3 years
Undergraduate pharmacy students’ attitudes and perceived barriers toward provision of pharmaceutical care: a multi-institutional study in Nepal. Integrated Pharmacy Research & Practice 2019; 8:47
Impact assessment of pharmacovigilance-related educational intervention on nursing students’ knowledge, attitude and practice: a pre-post study. Journal of Nursing Education and Practice 2019; 9 (6): 98-106
The use of topical clobetasol among the women in hail region, Saudi Arabia: a cross-sectional study on knowledge and practice. Journal of Pharmaceutical Research International. 2019 Nov 22:1-7
Overview, Challenges and Future Prospects of Drug Information Services in Nepal: A Reflective Commentary. Journal of Multidisciplinary Healthcare. 2020;13:287
Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal. Therapeutic Advances in Drug Safety 2020 May;11:2042098620922480.
Assessment of the Knowledge and Self-medication Practices towards Antibiotics among Future Healthcare Professionals in Ajman, United Arab Emirates. JPRI, 32(9): 24-34, 2020; Article no.JPRI.57354
Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future. Therapeutic Advances in Drug Safety. 2020 Aug;11:2042098620938595.
Knowledge, awareness and preparedness regarding coronavirus disease 2019 pandemic among community pharmacy practitioners working in Kathmandu, Nepal: A pilot study. SAGE Open Medicine 2020; 8: 1-11
Patient Safety Culture in Handling Prescriptions and Interprofessional Collaboration Practices Amongst Community Pharmacists: An Investigative Simulated Patient Study from the United Arab Emirates. Risk Manag Healthc Policy 2020;13:3201-9
Assessment of a pharmacovigilance module: an interventional study on knowledge, attitude and practice of pharmacy students. Journal of Pharmacy and Bioallied Sciences
Nationwide survey on attitudes and perceived barriers toward provision of pharmaceutical care among final year undergraduate pharmacy students in the United Arab Emirates. PLoS One. 2021 Feb 16;16(2):e0246934
Knowledge and Practice on Ecopharmacovigilance and Medicine Storage Amongst Medical and Dental Students in Lalitpur, Nepal. Risk management and healthcare policy. 2021;14:793
Alabid AH, Ibrahim MI, Hassali MA, Palaian S, Community pharmacists' awareness toward their roles in healthcare and interaction with general practitioners: A cross-sectional study, Journal of Pharmacy And Bioallied Sciences, Apr 2021
Pharmacovigilance of COVID-19 vaccines in the context of Nepal: an assessment based on early adverse drug reaction reports. Journal of Pharmaceutical Health Services Research
. Respiratory concerns of gabapentin and pregabalin: What does it mean to the pharmacovigilance systems in developing countries? [version 2; peer review: 2 approved]. F1000Research 2021, 9:32
Jha N, Palaian S, Shankar PR, KC S, Kshetry PB.
, Situation analysis of the pharmacovigilance system in Nepal using the indicator-based pharmacovigilance assessment tool (IPAT), Journal of Pharmaceutical Health Services Research, Nov 2021
About the journal
Journal Name
Journal of Pharmaceutical Health Services Research
Shankar PR, Palaian S, Vannal V, Sreeramareddy CT, Non-pharmacological infection prevention and control interventions in COVID-19: What does the current evidence say?, International Journal of Preventive Medicine., Jan 2022
Alomar M, Palaian S, Shanableh S., Perceived stress and quality of life among final-year pharmacy students in the united arab emirates during covid-19 pandemic lockdown, Advances in Medical Education and Practice, Nov 2021
Paudel S., Palaian S, Shankar PR, Subedi N., Risk perception and hesitancy toward COVID-19 vaccination among healthcare workers and staff at a medical college in Nepal, Risk Management and Healthcare Policy, Jun 2021
About the journal
Journal Name
Risk Management and Healthcare Policy
Publisher
Dove Medical Press Ltd
Conference Presentation
Community pharmacy practice evaluation in the United Arab Emirates using simulated patients with common cold. At the 2020 International Conference of Pharmacoepidemiology and Therapeutic Risk Management September 15-16, 2020; www.ICPE-AllAccess.org
Community pharmacy practice evaluation in the United Arab Emirates using simulated patients with common cold. At the 2020 International Conference of Pharmacoepidemiology and Therapeutic Risk Management September 15-16, 2020; www.ICPE-AllAccess.org
Memberships, Awards and Honors
Membership at The International Society for Pharmacoepidemiology
Membership at The International Society for Pharmacoepidemiology